Skip to content

Were Any Orphan Drug Companies Among TheStreet.com’s Top BioTech CEOs of 2012 ?

December 17, 2012

TheStreet.com’s readers voted on the top BioTech CEO’s for 2012 and here are the results :

  1. Leonard Schleifer of Regeneron Pharmaceuticals
  2. Tony Coles of Onyx Pharmaceuticals – in 2012 FDA approval of Kyprolis (Carfilzomib) for Multiple Myeloma (MM)
  3. Chris Garabedian of Sarepta Therapeutics – orphan drug Eteplirsen for Duchenne Muscular Dystrophy (DMD)
  4. John Martin of Gilead Sciences.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: